Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant

Karen E. Mooney, Michael B. Altman, Sharbacha Edward, Jose Garcia-Ramirez, Maria A. Thomas, Imran Zoberi, Todd DeWees, Daniel Mullen, Jacqueline E. Zoberi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose Current guidelines for high-dose-rate accelerated partial breast irradiation using single-entry implants are based on the National Surgical Adjuvant Breast and Bowel Project B-39/Radiation Therapy Oncology Group 0413 protocol, which assumed a balloon implant geometry. We have developed robust plan evaluation criteria specifically for the strut-adjusted volume implant (SAVI). Methods and Materials Plan evaluation criteria were established using a “training data set” of 62 SAVI treatment plans and included the percentage volume of target receiving 90%, 95%, and 100% of the prescription dose (V90, V95, and V100), the absolute volume of target receiving 150% and 200% of prescription (V150 and V200), and the maximum doses to skin (Dskin max) and ribs (Drib max). “Ideal” and “expected” (routinely achievable) thresholds were determined for each criterion and compared to B-39 guidelines. A “test data set” collected from the next 25 patients was analyzed using the developed plan evaluation criteria. Results Ideal (expected) dosimetric thresholds established from the training data set were V90 ≥ 98% (95%), V95 ≥ 95% (92%), V100 ≥ 91% (88%), Dskin max < 90% (100%), and Drib max < 100%. Thresholds for V150 and V200 were stratified by SAVI size: V150 ≤ 30 cc (50 cc) and V200 ≤ 15 cc (20 cc) for 6–1 and Mini; V150 ≤ 50 cc (50 cc) and V200 ≤ 20 cc (20 cc) for 8–1 and 10–1. There was no significant difference between the training and test data sets in the fractions of patients meeting the criteria. Overall, 58% and 95% of 87 plans met all ideal and all expected criteria, respectively. Conclusions The plan evaluation criteria developed specifically for the SAVI device are robust, providing increased target coverage and increased skin sparing compared to B-39 guidelines.

Original languageEnglish (US)
Pages (from-to)616-624
Number of pages9
JournalBrachytherapy
Volume15
Issue number5
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Breast
Guidelines
Prescriptions
Skin
Radiation Oncology
Ribs
Radiotherapy
Equipment and Supplies
Datasets
Therapeutics

Keywords

  • APBI
  • Breast brachytherapy
  • SAVI
  • Treatment planning

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Mooney, K. E., Altman, M. B., Edward, S., Garcia-Ramirez, J., Thomas, M. A., Zoberi, I., ... Zoberi, J. E. (2016). Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant. Brachytherapy, 15(5), 616-624. https://doi.org/10.1016/j.brachy.2016.05.002

Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant. / Mooney, Karen E.; Altman, Michael B.; Edward, Sharbacha; Garcia-Ramirez, Jose; Thomas, Maria A.; Zoberi, Imran; DeWees, Todd; Mullen, Daniel; Zoberi, Jacqueline E.

In: Brachytherapy, Vol. 15, No. 5, 01.09.2016, p. 616-624.

Research output: Contribution to journalArticle

Mooney, KE, Altman, MB, Edward, S, Garcia-Ramirez, J, Thomas, MA, Zoberi, I, DeWees, T, Mullen, D & Zoberi, JE 2016, 'Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant', Brachytherapy, vol. 15, no. 5, pp. 616-624. https://doi.org/10.1016/j.brachy.2016.05.002
Mooney KE, Altman MB, Edward S, Garcia-Ramirez J, Thomas MA, Zoberi I et al. Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant. Brachytherapy. 2016 Sep 1;15(5):616-624. https://doi.org/10.1016/j.brachy.2016.05.002
Mooney, Karen E. ; Altman, Michael B. ; Edward, Sharbacha ; Garcia-Ramirez, Jose ; Thomas, Maria A. ; Zoberi, Imran ; DeWees, Todd ; Mullen, Daniel ; Zoberi, Jacqueline E. / Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant. In: Brachytherapy. 2016 ; Vol. 15, No. 5. pp. 616-624.
@article{7ff4c6602fd7431e870897390dae2d7a,
title = "Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant",
abstract = "Purpose Current guidelines for high-dose-rate accelerated partial breast irradiation using single-entry implants are based on the National Surgical Adjuvant Breast and Bowel Project B-39/Radiation Therapy Oncology Group 0413 protocol, which assumed a balloon implant geometry. We have developed robust plan evaluation criteria specifically for the strut-adjusted volume implant (SAVI). Methods and Materials Plan evaluation criteria were established using a “training data set” of 62 SAVI treatment plans and included the percentage volume of target receiving 90{\%}, 95{\%}, and 100{\%} of the prescription dose (V90, V95, and V100), the absolute volume of target receiving 150{\%} and 200{\%} of prescription (V150 and V200), and the maximum doses to skin (Dskin max) and ribs (Drib max). “Ideal” and “expected” (routinely achievable) thresholds were determined for each criterion and compared to B-39 guidelines. A “test data set” collected from the next 25 patients was analyzed using the developed plan evaluation criteria. Results Ideal (expected) dosimetric thresholds established from the training data set were V90 ≥ 98{\%} (95{\%}), V95 ≥ 95{\%} (92{\%}), V100 ≥ 91{\%} (88{\%}), Dskin max < 90{\%} (100{\%}), and Drib max < 100{\%}. Thresholds for V150 and V200 were stratified by SAVI size: V150 ≤ 30 cc (50 cc) and V200 ≤ 15 cc (20 cc) for 6–1 and Mini; V150 ≤ 50 cc (50 cc) and V200 ≤ 20 cc (20 cc) for 8–1 and 10–1. There was no significant difference between the training and test data sets in the fractions of patients meeting the criteria. Overall, 58{\%} and 95{\%} of 87 plans met all ideal and all expected criteria, respectively. Conclusions The plan evaluation criteria developed specifically for the SAVI device are robust, providing increased target coverage and increased skin sparing compared to B-39 guidelines.",
keywords = "APBI, Breast brachytherapy, SAVI, Treatment planning",
author = "Mooney, {Karen E.} and Altman, {Michael B.} and Sharbacha Edward and Jose Garcia-Ramirez and Thomas, {Maria A.} and Imran Zoberi and Todd DeWees and Daniel Mullen and Zoberi, {Jacqueline E.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.brachy.2016.05.002",
language = "English (US)",
volume = "15",
pages = "616--624",
journal = "Brachytherapy",
issn = "1538-4721",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Accelerated partial breast irradiation dosimetric criteria for the strut-adjusted volume implant

AU - Mooney, Karen E.

AU - Altman, Michael B.

AU - Edward, Sharbacha

AU - Garcia-Ramirez, Jose

AU - Thomas, Maria A.

AU - Zoberi, Imran

AU - DeWees, Todd

AU - Mullen, Daniel

AU - Zoberi, Jacqueline E.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Purpose Current guidelines for high-dose-rate accelerated partial breast irradiation using single-entry implants are based on the National Surgical Adjuvant Breast and Bowel Project B-39/Radiation Therapy Oncology Group 0413 protocol, which assumed a balloon implant geometry. We have developed robust plan evaluation criteria specifically for the strut-adjusted volume implant (SAVI). Methods and Materials Plan evaluation criteria were established using a “training data set” of 62 SAVI treatment plans and included the percentage volume of target receiving 90%, 95%, and 100% of the prescription dose (V90, V95, and V100), the absolute volume of target receiving 150% and 200% of prescription (V150 and V200), and the maximum doses to skin (Dskin max) and ribs (Drib max). “Ideal” and “expected” (routinely achievable) thresholds were determined for each criterion and compared to B-39 guidelines. A “test data set” collected from the next 25 patients was analyzed using the developed plan evaluation criteria. Results Ideal (expected) dosimetric thresholds established from the training data set were V90 ≥ 98% (95%), V95 ≥ 95% (92%), V100 ≥ 91% (88%), Dskin max < 90% (100%), and Drib max < 100%. Thresholds for V150 and V200 were stratified by SAVI size: V150 ≤ 30 cc (50 cc) and V200 ≤ 15 cc (20 cc) for 6–1 and Mini; V150 ≤ 50 cc (50 cc) and V200 ≤ 20 cc (20 cc) for 8–1 and 10–1. There was no significant difference between the training and test data sets in the fractions of patients meeting the criteria. Overall, 58% and 95% of 87 plans met all ideal and all expected criteria, respectively. Conclusions The plan evaluation criteria developed specifically for the SAVI device are robust, providing increased target coverage and increased skin sparing compared to B-39 guidelines.

AB - Purpose Current guidelines for high-dose-rate accelerated partial breast irradiation using single-entry implants are based on the National Surgical Adjuvant Breast and Bowel Project B-39/Radiation Therapy Oncology Group 0413 protocol, which assumed a balloon implant geometry. We have developed robust plan evaluation criteria specifically for the strut-adjusted volume implant (SAVI). Methods and Materials Plan evaluation criteria were established using a “training data set” of 62 SAVI treatment plans and included the percentage volume of target receiving 90%, 95%, and 100% of the prescription dose (V90, V95, and V100), the absolute volume of target receiving 150% and 200% of prescription (V150 and V200), and the maximum doses to skin (Dskin max) and ribs (Drib max). “Ideal” and “expected” (routinely achievable) thresholds were determined for each criterion and compared to B-39 guidelines. A “test data set” collected from the next 25 patients was analyzed using the developed plan evaluation criteria. Results Ideal (expected) dosimetric thresholds established from the training data set were V90 ≥ 98% (95%), V95 ≥ 95% (92%), V100 ≥ 91% (88%), Dskin max < 90% (100%), and Drib max < 100%. Thresholds for V150 and V200 were stratified by SAVI size: V150 ≤ 30 cc (50 cc) and V200 ≤ 15 cc (20 cc) for 6–1 and Mini; V150 ≤ 50 cc (50 cc) and V200 ≤ 20 cc (20 cc) for 8–1 and 10–1. There was no significant difference between the training and test data sets in the fractions of patients meeting the criteria. Overall, 58% and 95% of 87 plans met all ideal and all expected criteria, respectively. Conclusions The plan evaluation criteria developed specifically for the SAVI device are robust, providing increased target coverage and increased skin sparing compared to B-39 guidelines.

KW - APBI

KW - Breast brachytherapy

KW - SAVI

KW - Treatment planning

UR - http://www.scopus.com/inward/record.url?scp=84977539605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977539605&partnerID=8YFLogxK

U2 - 10.1016/j.brachy.2016.05.002

DO - 10.1016/j.brachy.2016.05.002

M3 - Article

C2 - 27349857

AN - SCOPUS:84977539605

VL - 15

SP - 616

EP - 624

JO - Brachytherapy

JF - Brachytherapy

SN - 1538-4721

IS - 5

ER -